insights_auto
Why is BOT up 8.33%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.013
arrow_upward
+8.33%(+0.0010) 1D
Oct 26, 4:10:16 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
43.08M
Avg. vol.
7.50M
Volume
7.60M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
43.08M
Avg. vol.
7.50M
Volume
7.60M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Yahoo Finance
·
56 minutes ago
Stock Market: Will S&P 500 Open Up or Down Today?
Bloomberg.com
·
16 hours ago
Zero-Day Option Traders Are Betting Against Big S&P 500 Swings
MarketWatch
·
16 hours ago
More than a third of S&P 500 companies are about to report earnings as market confidence cracks
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd